APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ivermectin for Human

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Ivermectin for Human Market Analysis and Forecast 2026-2032

2 January 2026194 pages

Choose your research edition.

Industry ResearchIvermectin for Human Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Ivermectin for Human Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Ivermectin for Human Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ivermectin for Human Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Ivermectin for Human Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Ivermectin for Human market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Ivermectin for Human is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Ivermectin for Human is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Ivermectin for Human is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Ivermectin for Human is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Ivermectin for Human include Arbor Pharms LLC, Edenbridge Pharms, Galderma Laboratories LP, Perrigo Company plc, TARO, TEVA Pharms USA, Wellona Pharma and Merck, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Ivermectin for Human, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ivermectin for Human, also provides the sales of main regions and countries. Of the upcoming market potential for Ivermectin for Human, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ivermectin for Human sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ivermectin for Human market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Ivermectin for Human sales, projected growth trends, production technology, application and end-user industry.

Ivermectin for Human Segment by Company

Arbor Pharms LLC

Edenbridge Pharms

Galderma Laboratories LP

Perrigo Company plc

TARO

TEVA Pharms USA

Wellona Pharma

Merck

Ivermectin for Human Segment by Type

Injection

Oral

Topical (Cream and Lotion)

Ivermectin for Human Segment by Application

For Onchocerciasis Treatment

For Headlice Treatment

Others

Ivermectin for Human Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ivermectin for Human market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ivermectin for Human and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ivermectin for Human.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Ivermectin for Human in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Ivermectin for Human manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ivermectin for Human sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ivermectin for Human Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Injection Major Manufacturers Table 3. Oral Major Manufacturers Table 4. Topical (Cream and Lotion) Major Manufacturers Table 5. Global Ivermectin for Human Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. For Onchocerciasis Treatment Major Manufacturers Table 7. For Headlice Treatment Major Manufacturers Table 8. Others Major Manufacturers Table 9. Ivermectin for Human Industry Trends Table 10. Ivermectin for Human Industry Drivers Table 11. Ivermectin for Human Industry Opportunities and Challenges Table 12. Ivermectin for Human Industry Restraints Table 13. Global Ivermectin for Human Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Ivermectin for Human Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Ivermectin for Human Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Ivermectin for Human Revenue Market Share by Region (2021-2026) Table 17. Global Ivermectin for Human Revenue Market Share by Region (2027-2032) Table 18. Global Ivermectin for Human Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Kg) Table 19. Global Ivermectin for Human Sales by Region (2021-2026) & (Kg) Table 20. Global Ivermectin for Human Sales by Region (2027-2032) & (Kg) Table 21. Global Ivermectin for Human Sales Market Share by Region (2021-2026) Table 22. Global Ivermectin for Human Sales Market Share by Region (2027-2032) Table 23. Global Ivermectin for Human Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Ivermectin for Human Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Ivermectin for Human Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Ivermectin for Human Sales Market Share by Manufacturers (2021-2026) Table 27. Global Ivermectin for Human Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 28. Global Ivermectin for Human Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Ivermectin for Human Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Ivermectin for Human Manufacturers, Product Type & Application Table 31. Global Ivermectin for Human Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Ivermectin for Human by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Ivermectin for Human Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Ivermectin for Human Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Ivermectin for Human Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Ivermectin for Human Revenue Market Share by Type (2021-2026) Table 38. Global Ivermectin for Human Revenue Market Share by Type (2027-2032) Table 39. Global Ivermectin for Human Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 40. Global Ivermectin for Human Sales by Type (2021-2026) & (Kg) Table 41. Global Ivermectin for Human Sales by Type (2027-2032) & (Kg) Table 42. Global Ivermectin for Human Sales Market Share by Type (2021-2026) Table 43. Global Ivermectin for Human Sales Market Share by Type (2027-2032) Table 44. Global Ivermectin for Human Price by Type (2021-2026) & (US$/Kg) Table 45. Global Ivermectin for Human Price by Type (2027-2032) & (US$/Kg) Table 46. Global Ivermectin for Human Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Ivermectin for Human Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Ivermectin for Human Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Ivermectin for Human Revenue Market Share by Application (2021-2026) Table 50. Global Ivermectin for Human Revenue Market Share by Application (2027-2032) Table 51. Global Ivermectin for Human Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 52. Global Ivermectin for Human Sales by Application (2021-2026) & (Kg) Table 53. Global Ivermectin for Human Sales by Application (2027-2032) & (Kg) Table 54. Global Ivermectin for Human Sales Market Share by Application (2021-2026) Table 55. Global Ivermectin for Human Sales Market Share by Application (2027-2032) Table 56. Global Ivermectin for Human Price by Application (2021-2026) & (US$/Kg) Table 57. Global Ivermectin for Human Price by Application (2027-2032) & (US$/Kg) Table 58. Arbor Pharms LLC Company Information Table 59. Arbor Pharms LLC Business Overview Table 60. Arbor Pharms LLC Ivermectin for Human Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 61. Arbor Pharms LLC Ivermectin for Human Product Portfolio Table 62. Arbor Pharms LLC Recent Development Table 63. Edenbridge Pharms Company Information Table 64. Edenbridge Pharms Business Overview Table 65. Edenbridge Pharms Ivermectin for Human Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 66. Edenbridge Pharms Ivermectin for Human Product Portfolio Table 67. Edenbridge Pharms Recent Development Table 68. Galderma Laboratories LP Company Information Table 69. Galderma Laboratories LP Business Overview Table 70. Galderma Laboratories LP Ivermectin for Human Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 71. Galderma Laboratories LP Ivermectin for Human Product Portfolio Table 72. Galderma Laboratories LP Recent Development Table 73. Perrigo Company plc Company Information Table 74. Perrigo Company plc Business Overview Table 75. Perrigo Company plc Ivermectin for Human Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 76. Perrigo Company plc Ivermectin for Human Product Portfolio Table 77. Perrigo Company plc Recent Development Table 78. TARO Company Information Table 79. TARO Business Overview Table 80. TARO Ivermectin for Human Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 81. TARO Ivermectin for Human Product Portfolio Table 82. TARO Recent Development Table 83. TEVA Pharms USA Company Information Table 84. TEVA Pharms USA Business Overview Table 85. TEVA Pharms USA Ivermectin for Human Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 86. TEVA Pharms USA Ivermectin for Human Product Portfolio Table 87. TEVA Pharms USA Recent Development Table 88. Wellona Pharma Company Information Table 89. Wellona Pharma Business Overview Table 90. Wellona Pharma Ivermectin for Human Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 91. Wellona Pharma Ivermectin for Human Product Portfolio Table 92. Wellona Pharma Recent Development Table 93. Merck Company Information Table 94. Merck Business Overview Table 95. Merck Ivermectin for Human Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 96. Merck Ivermectin for Human Product Portfolio Table 97. Merck Recent Development Table 98. North America Ivermectin for Human Revenue by Type (2021-2026) & (US$ Million) Table 99. North America Ivermectin for Human Revenue by Type (2027-2032) & (US$ Million) Table 100. North America Ivermectin for Human Sales by Type (2021-2026) & (Kg) Table 101. North America Ivermectin for Human Sales by Type (2027-2032) & (Kg) Table 102. North America Ivermectin for Human Sales Price by Type (2021-2026) & (US$/Kg) Table 103. North America Ivermectin for Human Sales Price by Type (2027-2032) & (US$/Kg) Table 104. North America Ivermectin for Human Revenue by Application (2021-2026) & (US$ Million) Table 105. North America Ivermectin for Human Revenue by Application (2027-2032) & (US$ Million) Table 106. North America Ivermectin for Human Sales by Application (2021-2026) & (Kg) Table 107. North America Ivermectin for Human Sales by Application (2027-2032) & (Kg) Table 108. North America Ivermectin for Human Sales Price by Application (2021-2026) & (US$/Kg) Table 109. North America Ivermectin for Human Sales Price by Application (2027-2032) & (US$/Kg) Table 110. North America Ivermectin for Human Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America Ivermectin for Human Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. North America Ivermectin for Human Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. North America Ivermectin for Human Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 114. North America Ivermectin for Human Sales by Country (2021-2026) & (Kg) Table 115. North America Ivermectin for Human Sales by Country (2027-2032) & (Kg) Table 116. North America Ivermectin for Human Sales Price by Country (2021-2026) & (US$/Kg) Table 117. North America Ivermectin for Human Sales Price by Country (2027-2032) & (US$/Kg) Table 118. United States Ivermectin for Human Revenue (2021-2032) & (US$ Million) Table 119. Canada Ivermectin for Human Revenue (2021-2032) & (US$ Million) Table 120. Europe Ivermectin for Human Revenue by Type (2021-2026) & (US$ Million) Table 121. Europe Ivermectin for Human Revenue by Type (2027-2032) & (US$ Million) Table 122. Europe Ivermectin for Human Sales by Type (2021-2026) & (Kg) Table 123. Europe Ivermectin for Human Sales by Type (2027-2032) & (Kg) Table 124. Europe Ivermectin for Human Sales Price by Type (2021-2026) & (US$/Kg) Table 125. Europe Ivermectin for Human Sales Price by Type (2027-2032) & (US$/Kg) Table 126. Europe Ivermectin for Human Revenue by Application (2021-2026) & (US$ Million) Table 127. Europe Ivermectin for Human Revenue by Application (2027-2032) & (US$ Million) Table 128. Europe Ivermectin for Human Sales by Application (2021-2026) & (Kg) Table 129. Europe Ivermectin for Human Sales by Application (2027-2032) & (Kg) Table 130. Europe Ivermectin for Human Sales Price by Application (2021-2026) & (US$/Kg) Table 131. Europe Ivermectin for Human Sales Price by Application (2027-2032) & (US$/Kg) Table 132. Europe Ivermectin for Human Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe Ivermectin for Human Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 134. Europe Ivermectin for Human Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 135. Europe Ivermectin for Human Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 136. Europe Ivermectin for Human Sales by Country (2021-2026) & (Kg) Table 137. Europe Ivermectin for Human Sales by Country (2027-2032) & (Kg) Table 138. Europe Ivermectin for Human Sales Price by Country (2021-2026) & (US$/Kg) Table 139. Europe Ivermectin for Human Sales Price by Country (2027-2032) & (US$/Kg) Table 140. Germany Ivermectin for Human Revenue (2021-2032) & (US$ Million) Table 141. France Ivermectin for Human Revenue (2021-2032) & (US$ Million) Table 142. U.K. Ivermectin for Human Revenue (2021-2032) & (US$ Million) Table 143. Italy Ivermectin for Human Revenue (2021-2032) & (US$ Million) Table 144. Netherlands Ivermectin for Human Revenue (2021-2032) & (US$ Million) Table 145. China Ivermectin for Human Revenue by Type (2021-2026) & (US$ Million) Table 146. China Ivermectin for Human Revenue by Type (2027-2032) & (US$ Million) Table 147. China Ivermectin for Human Sales by Type (2021-2026) & (Kg) Table 148. China Ivermectin for Human Sales by Type (2027-2032) & (Kg) Table 149. China Ivermectin for Human Sales Price by Type (2021-2026) & (US$/Kg) Table 150. China Ivermectin for Human Sales Price by Type (2027-2032) & (US$/Kg) Table 151. China Ivermectin for Human Revenue by Application (2021-2026) & (US$ Million) Table 152. China Ivermectin for Human Revenue by Application (2027-2032) & (US$ Million) Table 153. China Ivermectin for Human Sales by Application (2021-2026) & (Kg) Table 154. China Ivermectin for Human Sales by Application (2027-2032) & (Kg) Table 155. China Ivermectin for Human Sales Price by Application (2021-2026) & (US$/Kg) Table 156. China Ivermectin for Human Sales Price by Application (2027-2032) & (US$/Kg) Table 157. Asia Ivermectin for Human Revenue by Type (2021-2026) & (US$ Million) Table 158. Asia Ivermectin for Human Revenue by Type (2027-2032) & (US$ Million) Table 159. Asia Ivermectin for Human Sales by Type (2021-2026) & (Kg) Table 160. Asia Ivermectin for Human Sales by Type (2027-2032) & (Kg) Table 161. Asia Ivermectin for Human Sales Price by Type (2021-2026) & (US$/Kg) Table 162. Asia Ivermectin for Human Sales Price by Type (2027-2032) & (US$/Kg) Table 163. Asia Ivermectin for Human Revenue by Application (2021-2026) & (US$ Million) Table 164. Asia Ivermectin for Human Revenue by Application (2027-2032) & (US$ Million) Table 165. Asia Ivermectin for Human Sales by Application (2021-2026) & (Kg) Table 166. Asia Ivermectin for Human Sales by Application (2027-2032) & (Kg) Table 167. Asia Ivermectin for Human Sales Price by Application (2021-2026) & (US$/Kg) Table 168. Asia Ivermectin for Human Sales Price by Application (2027-2032) & (US$/Kg) Table 169. Asia Ivermectin for Human Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Asia Ivermectin for Human Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. Asia Ivermectin for Human Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. Asia Ivermectin for Human Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 173. Asia Ivermectin for Human Sales by Country (2021-2026) & (Kg) Table 174. Asia Ivermectin for Human Sales by Country (2027-2032) & (Kg) Table 175. Asia Ivermectin for Human Sales Price by Country (2021-2026) & (US$/Kg) Table 176. Asia Ivermectin for Human Sales Price by Country (2027-2032) & (US$/Kg) Table 177. Japan Ivermectin for Human Revenue (2021-2032) & (US$ Million) Table 178. South Korea Ivermectin for Human Revenue (2021-2032) & (US$ Million) Table 179. India Ivermectin for Human Revenue (2021-2032) & (US$ Million) Table 180. Australia Ivermectin for Human Revenue (2021-2032) & (US$ Million) Table 181. China Taiwan Ivermectin for Human Revenue (2021-2032) & (US$ Million) Table 182. Southeast Asia Ivermectin for Human Revenue (2021-2032) & (US$ Million) Table 183. SAMEA Ivermectin for Human Revenue by Type (2021-2026) & (US$ Million) Table 184. SAMEA Ivermectin for Human Revenue by Type (2027-2032) & (US$ Million) Table 185. SAMEA Ivermectin for Human Sales by Type (2021-2026) & (Kg) Table 186. SAMEA Ivermectin for Human Sales by Type (2027-2032) & (Kg) Table 187. SAMEA Ivermectin for Human Sales Price by Type (2021-2026) & (US$/Kg) Table 188. SAMEA Ivermectin for Human Sales Price by Type (2027-2032) & (US$/Kg) Table 189. SAMEA Ivermectin for Human Revenue by Application (2021-2026) & (US$ Million) Table 190. SAMEA Ivermectin for Human Revenue by Application (2027-2032) & (US$ Million) Table 191. SAMEA Ivermectin for Human Sales by Application (2021-2026) & (Kg) Table 192. SAMEA Ivermectin for Human Sales by Application (2027-2032) & (Kg) Table 193. SAMEA Ivermectin for Human Sales Price by Application (2021-2026) & (US$/Kg) Table 194. SAMEA Ivermectin for Human Sales Price by Application (2027-2032) & (US$/Kg) Table 195. SAMEA Ivermectin for Human Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. SAMEA Ivermectin for Human Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. SAMEA Ivermectin for Human Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. SAMEA Ivermectin for Human Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 199. SAMEA Ivermectin for Human Sales by Country (2021-2026) & (Kg) Table 200. SAMEA Ivermectin for Human Sales by Country (2027-2032) & (Kg) Table 201. SAMEA Ivermectin for Human Sales Price by Country (2021-2026) & (US$/Kg) Table 202. SAMEA Ivermectin for Human Sales Price by Country (2027-2032) & (US$/Kg) Table 203. Brazil Ivermectin for Human Revenue (2021-2032) & (US$ Million) Table 204. Argentina Ivermectin for Human Revenue (2021-2032) & (US$ Million) Table 205. Chile Ivermectin for Human Revenue (2021-2032) & (US$ Million) Table 206. Colombia Ivermectin for Human Revenue (2021-2032) & (US$ Million) Table 207. Peru Ivermectin for Human Revenue (2021-2032) & (US$ Million) Table 208. Saudi Arabia Ivermectin for Human Revenue (2021-2032) & (US$ Million) Table 209. Israel Ivermectin for Human Revenue (2021-2032) & (US$ Million) Table 210. UAE Ivermectin for Human Revenue (2021-2032) & (US$ Million) Table 211. Turkey Ivermectin for Human Revenue (2021-2032) & (US$ Million) Table 212. Iran Ivermectin for Human Revenue (2021-2032) & (US$ Million) Table 213. Egypt Ivermectin for Human Revenue (2021-2032) & (US$ Million) Table 214. Key Raw Materials Table 215. Raw Materials Key Suppliers Table 216. Ivermectin for Human Distributors List Table 217. Ivermectin for Human Customers List Table 218. Research Programs/Design for This Report Table 219. Authors List of This Report Table 220. Secondary Sources Table 221. Primary Sources List of Figures Figure 1. Ivermectin for Human Image Figure 2. Global Ivermectin for Human Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ivermectin for Human Market Size Share 2021 VS 2025 VS 2032 Figure 4. Injection Image Figure 5. Oral Image Figure 6. Topical (Cream and Lotion) Image Figure 7. Global Ivermectin for Human Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Ivermectin for Human Market Size Share 2021 VS 2025 VS 2032 Figure 9. For Onchocerciasis Treatment Image Figure 10. For Headlice Treatment Image Figure 11. Others Image Figure 12. Global Ivermectin for Human Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Ivermectin for Human Revenue (2021-2032) & (US$ Million) Figure 14. Global Ivermectin for Human Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Ivermectin for Human Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Ivermectin for Human Revenue Market Share by Region (2021-2032) Figure 17. Global Ivermectin for Human Sales (2021-2032) & (Kg) Figure 18. Global Ivermectin for Human Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 19. Global Ivermectin for Human Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Ivermectin for Human Sales YoY (2021-2032) & (Kg) Figure 21. Europe Ivermectin for Human Sales YoY (2021-2032) & (Kg) Figure 22. China Ivermectin for Human Sales YoY (2021-2032) & (Kg) Figure 23. Asia (Excluding China) Ivermectin for Human Sales YoY (2021-2032) & (Kg) Figure 24. South America, Middle East and Africa Ivermectin for Human Sales YoY (2021-2032) & (Kg) Figure 25. Global Ivermectin for Human Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Ivermectin for Human Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Ivermectin for Human Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Ivermectin for Human Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Ivermectin for Human Revenue Market Share by Type (2021-2032) Figure 31. Global Ivermectin for Human Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 32. Global Ivermectin for Human Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Ivermectin for Human Sales Market Share by Type (2021-2032) Figure 34. Global Ivermectin for Human Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Ivermectin for Human Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Ivermectin for Human Revenue Market Share by Application (2021-2032) Figure 37. Global Ivermectin for Human Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 38. Global Ivermectin for Human Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Ivermectin for Human Sales Market Share by Application (2021-2032) Figure 40. North America Ivermectin for Human Revenue Share by Type (2021-2032) Figure 41. North America Ivermectin for Human Sales Share by Type (2021-2032) Figure 42. North America Ivermectin for Human Revenue Share by Application (2021-2032) Figure 43. North America Ivermectin for Human Sales Share by Application (2021-2032) Figure 44. North America Ivermectin for Human Revenue Share by Country (2021-2032) Figure 45. North America Ivermectin for Human Sales Share by Country (2021-2032) Figure 46. Europe Ivermectin for Human Revenue Share by Type (2021-2032) Figure 47. Europe Ivermectin for Human Sales Share by Type (2021-2032) Figure 48. Europe Ivermectin for Human Revenue Share by Application (2021-2032) Figure 49. Europe Ivermectin for Human Sales Share by Application (2021-2032) Figure 50. Europe Ivermectin for Human Revenue Share by Country (2021-2032) Figure 51. Europe Ivermectin for Human Sales Share by Country (2021-2032) Figure 52. China Ivermectin for Human Revenue Share by Type (2021-2032) Figure 53. China Ivermectin for Human Sales Share by Type (2021-2032) Figure 54. China Ivermectin for Human Revenue Share by Application (2021-2032) Figure 55. China Ivermectin for Human Sales Share by Application (2021-2032) Figure 56. Asia Ivermectin for Human Revenue Share by Type (2021-2032) Figure 57. Asia Ivermectin for Human Sales Share by Type (2021-2032) Figure 58. Asia Ivermectin for Human Revenue Share by Application (2021-2032) Figure 59. Asia Ivermectin for Human Sales Share by Application (2021-2032) Figure 60. Asia Ivermectin for Human Revenue Share by Country (2021-2032) Figure 61. Asia Ivermectin for Human Sales Share by Country (2021-2032) Figure 62. SAMEA Ivermectin for Human Revenue Share by Type (2021-2032) Figure 63. SAMEA Ivermectin for Human Sales Share by Type (2021-2032) Figure 64. SAMEA Ivermectin for Human Revenue Share by Application (2021-2032) Figure 65. SAMEA Ivermectin for Human Sales Share by Application (2021-2032) Figure 66. SAMEA Ivermectin for Human Revenue Share by Country (2021-2032) Figure 67. SAMEA Ivermectin for Human Sales Share by Country (2021-2032) Figure 68. Ivermectin for Human Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Ivermectin for Human Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Oral
  • Topical (Cream and Lotion)
Applications
  • For Onchocerciasis Treatment
  • For Headlice Treatment
  • Others
Companies covered
  • Arbor Pharms LLC
  • Edenbridge Pharms
  • Galderma Laboratories LP
  • Perrigo Company plc
  • TARO
  • TEVA Pharms USA
  • Wellona Pharma
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ivermectin for Human Market by Type
  3. 1.2.1 Global Ivermectin for Human Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Injection
  5. 1.2.3 Oral
  6. 1.2.4 Topical (Cream and Lotion)
  7. 1.3 Ivermectin for Human Market by Application
  8. 1.3.1 Global Ivermectin for Human Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 For Onchocerciasis Treatment
  10. 1.3.3 For Headlice Treatment
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Ivermectin for Human Market Dynamics
  1. 2.1 Ivermectin for Human Industry Trends
  2. 2.2 Ivermectin for Human Industry Drivers
  3. 2.3 Ivermectin for Human Industry Opportunities and Challenges
  4. 2.4 Ivermectin for Human Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Ivermectin for Human Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Ivermectin for Human Revenue by Region
  3. 3.2.1 Global Ivermectin for Human Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ivermectin for Human Revenue by Region (2021-2026)
  5. 3.2.3 Global Ivermectin for Human Revenue by Region (2027-2032)
  6. 3.2.4 Global Ivermectin for Human Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Ivermectin for Human Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Ivermectin for Human Sales by Region
  9. 3.4.1 Global Ivermectin for Human Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Ivermectin for Human Sales by Region (2021-2026)
  11. 3.4.3 Global Ivermectin for Human Sales by Region (2027-2032)
  12. 3.4.4 Global Ivermectin for Human Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Ivermectin for Human Revenue by Manufacturers
  2. 4.1.1 Global Ivermectin for Human Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Ivermectin for Human Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Ivermectin for Human Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ivermectin for Human Sales by Manufacturers
  6. 4.2.1 Global Ivermectin for Human Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Ivermectin for Human Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Ivermectin for Human Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Ivermectin for Human Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Ivermectin for Human Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Ivermectin for Human Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Ivermectin for Human Manufacturers, Product Type & Application
  13. 4.7 Global Ivermectin for Human Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Ivermectin for Human Market CR5 and HHI
  16. 4.8.2 2025 Ivermectin for Human Tier 1, Tier 2, and Tier 3
5 Ivermectin for Human Market by Type
  1. 5.1 Global Ivermectin for Human Revenue by Type
  2. 5.1.1 Global Ivermectin for Human Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Ivermectin for Human Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Ivermectin for Human Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Ivermectin for Human Sales by Type
  6. 5.2.1 Global Ivermectin for Human Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ivermectin for Human Sales by Type (2021-2032) & (Kg)
  8. 5.2.3 Global Ivermectin for Human Sales Market Share by Type (2021-2032)
  9. 5.3 Global Ivermectin for Human Price by Type
6 Ivermectin for Human Market by Application
  1. 6.1 Global Ivermectin for Human Revenue by Application
  2. 6.1.1 Global Ivermectin for Human Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Ivermectin for Human Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Ivermectin for Human Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Ivermectin for Human Sales by Application
  6. 6.2.1 Global Ivermectin for Human Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Ivermectin for Human Sales by Application (2021-2032) & (Kg)
  8. 6.2.3 Global Ivermectin for Human Sales Market Share by Application (2021-2032)
  9. 6.3 Global Ivermectin for Human Price by Application
7 Company Profiles
  1. 7.1 Arbor Pharms LLC
  2. 7.1.1 Arbor Pharms LLC Company Information
  3. 7.1.2 Arbor Pharms LLC Business Overview
  4. 7.1.3 Arbor Pharms LLC Ivermectin for Human Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Arbor Pharms LLC Ivermectin for Human Product Portfolio
  6. 7.1.5 Arbor Pharms LLC Recent Developments
  7. 7.2 Edenbridge Pharms
  8. 7.2.1 Edenbridge Pharms Company Information
  9. 7.2.2 Edenbridge Pharms Business Overview
  10. 7.2.3 Edenbridge Pharms Ivermectin for Human Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Edenbridge Pharms Ivermectin for Human Product Portfolio
  12. 7.2.5 Edenbridge Pharms Recent Developments
  13. 7.3 Galderma Laboratories LP
  14. 7.3.1 Galderma Laboratories LP Company Information
  15. 7.3.2 Galderma Laboratories LP Business Overview
  16. 7.3.3 Galderma Laboratories LP Ivermectin for Human Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Galderma Laboratories LP Ivermectin for Human Product Portfolio
  18. 7.3.5 Galderma Laboratories LP Recent Developments
  19. 7.4 Perrigo Company plc
  20. 7.4.1 Perrigo Company plc Company Information
  21. 7.4.2 Perrigo Company plc Business Overview
  22. 7.4.3 Perrigo Company plc Ivermectin for Human Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Perrigo Company plc Ivermectin for Human Product Portfolio
  24. 7.4.5 Perrigo Company plc Recent Developments
  25. 7.5 TARO
  26. 7.5.1 TARO Company Information
  27. 7.5.2 TARO Business Overview
  28. 7.5.3 TARO Ivermectin for Human Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 TARO Ivermectin for Human Product Portfolio
  30. 7.5.5 TARO Recent Developments
  31. 7.6 TEVA Pharms USA
  32. 7.6.1 TEVA Pharms USA Company Information
  33. 7.6.2 TEVA Pharms USA Business Overview
  34. 7.6.3 TEVA Pharms USA Ivermectin for Human Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 TEVA Pharms USA Ivermectin for Human Product Portfolio
  36. 7.6.5 TEVA Pharms USA Recent Developments
  37. 7.7 Wellona Pharma
  38. 7.7.1 Wellona Pharma Company Information
  39. 7.7.2 Wellona Pharma Business Overview
  40. 7.7.3 Wellona Pharma Ivermectin for Human Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Wellona Pharma Ivermectin for Human Product Portfolio
  42. 7.7.5 Wellona Pharma Recent Developments
  43. 7.8 Merck
  44. 7.8.1 Merck Company Information
  45. 7.8.2 Merck Business Overview
  46. 7.8.3 Merck Ivermectin for Human Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Merck Ivermectin for Human Product Portfolio
  48. 7.8.5 Merck Recent Developments
8 North America
  1. 8.1 North America Ivermectin for Human Market Size by Type
  2. 8.1.1 North America Ivermectin for Human Revenue by Type (2021-2032)
  3. 8.1.2 North America Ivermectin for Human Sales by Type (2021-2032)
  4. 8.1.3 North America Ivermectin for Human Price by Type (2021-2032)
  5. 8.2 North America Ivermectin for Human Market Size by Application
  6. 8.2.1 North America Ivermectin for Human Revenue by Application (2021-2032)
  7. 8.2.2 North America Ivermectin for Human Sales by Application (2021-2032)
  8. 8.2.3 North America Ivermectin for Human Price by Application (2021-2032)
  9. 8.3 North America Ivermectin for Human Market Size by Country
  10. 8.3.1 North America Ivermectin for Human Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Ivermectin for Human Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Ivermectin for Human Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Ivermectin for Human Market Size by Type
  2. 9.1.1 Europe Ivermectin for Human Revenue by Type (2021-2032)
  3. 9.1.2 Europe Ivermectin for Human Sales by Type (2021-2032)
  4. 9.1.3 Europe Ivermectin for Human Price by Type (2021-2032)
  5. 9.2 Europe Ivermectin for Human Market Size by Application
  6. 9.2.1 Europe Ivermectin for Human Revenue by Application (2021-2032)
  7. 9.2.2 Europe Ivermectin for Human Sales by Application (2021-2032)
  8. 9.2.3 Europe Ivermectin for Human Price by Application (2021-2032)
  9. 9.3 Europe Ivermectin for Human Market Size by Country
  10. 9.3.1 Europe Ivermectin for Human Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Ivermectin for Human Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Ivermectin for Human Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Ivermectin for Human Market Size by Type
  2. 10.1.1 China Ivermectin for Human Revenue by Type (2021-2032)
  3. 10.1.2 China Ivermectin for Human Sales by Type (2021-2032)
  4. 10.1.3 China Ivermectin for Human Price by Type (2021-2032)
  5. 10.2 China Ivermectin for Human Market Size by Application
  6. 10.2.1 China Ivermectin for Human Revenue by Application (2021-2032)
  7. 10.2.2 China Ivermectin for Human Sales by Application (2021-2032)
  8. 10.2.3 China Ivermectin for Human Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ivermectin for Human Market Size by Type
  2. 11.1.1 Asia Ivermectin for Human Revenue by Type (2021-2032)
  3. 11.1.2 Asia Ivermectin for Human Sales by Type (2021-2032)
  4. 11.1.3 Asia Ivermectin for Human Price by Type (2021-2032)
  5. 11.2 Asia Ivermectin for Human Market Size by Application
  6. 11.2.1 Asia Ivermectin for Human Revenue by Application (2021-2032)
  7. 11.2.2 Asia Ivermectin for Human Sales by Application (2021-2032)
  8. 11.2.3 Asia Ivermectin for Human Price by Application (2021-2032)
  9. 11.3 Asia Ivermectin for Human Market Size by Country
  10. 11.3.1 Asia Ivermectin for Human Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Ivermectin for Human Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Ivermectin for Human Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ivermectin for Human Market Size by Type
  2. 12.1.1 SAMEA Ivermectin for Human Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Ivermectin for Human Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Ivermectin for Human Price by Type (2021-2032)
  5. 12.2 SAMEA Ivermectin for Human Market Size by Application
  6. 12.2.1 SAMEA Ivermectin for Human Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Ivermectin for Human Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Ivermectin for Human Price by Application (2021-2032)
  9. 12.3 SAMEA Ivermectin for Human Market Size by Country
  10. 12.3.1 SAMEA Ivermectin for Human Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Ivermectin for Human Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Ivermectin for Human Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Ivermectin for Human Value Chain Analysis
  2. 13.1.1 Ivermectin for Human Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Ivermectin for Human Production Mode & Process
  6. 13.2 Ivermectin for Human Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Ivermectin for Human Distributors
  9. 13.2.3 Ivermectin for Human Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst